LivaNova
Builds heart-lung systems and implantable stimulation devices for epilepsy, depression and sleep apnea.
$80.32
After-hours close−0.02 (−0.02%)
At close$80.34(+0.39%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 118.62%Insiders 0.42%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 54.93M · Float 54.70M · 99.6% free float
Institutions13F, as of Jun 30, 2026
309 holders · 65.16M shares · 57 new positions · 178 increased · 84 reduced · 42 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.57M | 13.77% | +426.4K | Aug 7, 2026 |
| Primecap Management Co/CA/ | 4.17M | 7.59% | −38.7K | Aug 14, 2026 |
| FMR LLC | 3.15M | 5.73% | +480.4K | Aug 13, 2026 |
| Hood River Capital Management LLC | 2.57M | 4.67% | +1.93M | Aug 14, 2026 |
| AQR Capital Management LLC | 2.36M | 4.29% | −138.2K | Aug 14, 2026 |
| Invesco Ltd. | 2.24M | 4.07% | +613.1K | Aug 14, 2026 |
| Artisan Partners Limited Partnership | 2.22M | 4.05% | +101.9K | Aug 13, 2026 |
| State Street Corp | 2.17M | 3.94% | +93.2K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 12.70% | 6.92M | 13G | Jul 18, 2025 ↗ |
| Primecap Management Co/CA/ | 7.74% | 4.22M | 13G | Feb 12, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Alex Shvartsburg | officer: Chief Financial Officer | 44.6K | 0.08% | Apr 1, 2026 |
| William A. Kozy | director | 37.6K | 0.07% | Jun 17, 2026 |
| Stephanie Bolton | officer: President, Global Epilepsy | 22.2K | 0.04% | Apr 1, 2026 |
| Seng Stacy Enxing | director | 15.3K | 0.03% | Jun 17, 2026 |
| Vladimir Makatsaria | director, officer: Chief Executive Officer | 14.2K | 0.03% | Apr 1, 2026 |
| Todd C. Schermerhorn | director | 12.6K | 0.02% | Jun 17, 2026 |
| Sharon O'Kane | director | 11.3K | 0.02% | Jun 17, 2025 |
| Franco Poletti | officer: President, Cardiopulmonary | 10.8K | 0.02% | Apr 1, 2026 |
| Peter M. Wilver | director | 10.3K | 0.02% | Jun 17, 2026 |
| Brooke Story | director | 9.8K | 0.02% | Jun 17, 2026 |
1 ten-percent owner holds 4.86M shares by Form 4, outside the officers-and-directors figure above · 28 people have not refiled in the last 18 months (660.8K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 11, 2026 | Ahmet Tezelofficer: Chief Innovation Officer | Sale | 2,675 | $77.74 | 6,090 |
| Jun 15, 2026 | Francesco Bianchidirector | Sale | 1,200 | $80.19 | 9,584 |
| May 26, 2026 | Francesco Bianchidirector | Sale | 1,800 | $75.75 | 7,228 |
| Nov 18, 2025 | Brooke Storydirector | Sale | 250 | $53.94 | 6,232 |
CongressHouse and Senate disclosures
Not reported.